teduglutide · Takeda Pharms Usa · NDA 203441
Gattex Kit
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 203441 · 001 · RLD | powder, subcutaneous | 5MG/VIAL | open |
Expired or delisted (5)
- US 7847061 · — · 1 May 2026
- US 9060992 · — · 1 May 2026
- US 7847061 · use U-1320 · 1 Nov 2025 · delisted
- US 9060992 · use U-1320 · 1 Nov 2025 · delisted
- ODE-240 · 16 May 2026